Pacer Advisors, Inc. Gossamer Bio, Inc. Transaction History

Pacer Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 21, 2021	SELL	$8.0 - $9.75 $32,472 - $39,575	-4,059 Closed	0 $0
Q1 2021 Apr 05, 2021	BUY	$8.63 - $10.94 $4,366 - $5,535	506 Added 14.24%	4,059 $38,000
Q4 2020 Jan 20, 2021	BUY	$8.3 - $13.59 $14,151 - $23,170	1,705 Added 92.26%	3,553 $34,000
Q3 2020 Oct 19, 2020	BUY	$11.3 - $14.75 $20,882 - $27,258	1,848 New	1,848 $23,000

108

167M

430K

519K

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $80.8M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Pacer Advisors, Inc. with notifications on news.